Novartis plots cardio trial in UK as London HQ opens

Novartis has announced the beginnings of a major cardiovascular outcomes trial in the UK, as it opened a new headquarters in London.

After rejection, NICE agrees to look again at migraine drug ...

Child with rare disease takes NICE to court over access to l...

NICE’s decision-making process will come under legal scrutiny in court this week, after a child and her family claimed the NHS cost-effectiveness body is unlawfully limiting access to a lif

Digital interventions could help behaviour change, says NICE

The UK’s health watchdog has said health professionals can consider digital and mobile interventions as a supplement to regular services to support behaviour change in people at risk of developi

NHS patients denied new lung cancer drug after another NICE ...

Certain untreated lung cancer patients on England's NHS will have to make do with older drugs after NICE ruled in final guidance that AstraZeneca’s Tagrisso (osimertinib) is not cost-effect

NICE rejects Astellas' Xospata in AML, queries MSD's Keytrud...

NICE has been busy with announcements today, rejecting Astellas’ Xospata for a certain type of acute myeloid leukaemia (AML) and querying evidence for MSD's Keytruda in head and neck cancer